ECLCX
Price
$28.68
Change
-$0.06 (-0.21%)
Updated
Jun 2 closing price
Net Assets
462.37M
RGAEX
Price
$87.32
Change
-$0.28 (-0.32%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

ECLCX vs RGAEX

Header iconECLCX vs RGAEX Comparison
Open Charts ECLCX vs RGAEXBanner chart's image
ECLCX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
ECLCX vs. RGAEX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECLCX is a Buy and RGAEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 338B vs. ECLCX (462M). RGAEX pays higher dividends than ECLCX: RGAEX (0.21) vs ECLCX (0.00). ECLCX was incepted earlier than RGAEX: ECLCX (24 years) vs RGAEX (24 years). ECLCX (1.79) is less costly to investors than RGAEX (0.63). RGAEX is a more actively managed with annual turnover of: 32.00 vs. ECLCX (20.00). RGAEX has a lower initial minimum investment than ECLCX: RGAEX (250) vs ECLCX (1000). RGAEX annual gain was more profitable for investors over the last year : 14.83 vs. ECLCX (0.07). RGAEX return over 5 years is better than : 24.89 vs. ECLCX (-4.49).
ECLCXRGAEXECLCX / RGAEX
Total Expense Ratio1.790.63284%
Annual Report Gross Expense Ratio1.790.63284%
Fund Existence24 years24 years-
Gain YTD8.86410.42585%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.21-
Returns for 1 year0.0714.830%
Returns for 3 years20.9153.2039%
Returns for 5 years-4.4924.89-18%
Returns for 10 years47.69112.5242%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYAB0.670.04
+5.56%
Cyabra Inc.
VRSN297.410.82
+0.28%
VeriSign
NABL4.17-0.07
-1.65%
N-able
MMSI60.89-1.16
-1.87%
Merit Medical Systems
ANTX4.06-0.15
-3.56%
AN2 Therapeutics